Duysinx B, Corhay J-L, Larock M-P, Withofs N, Bury T, Hustinx R, Louis R
Chest Clinic, Sart-Tilman University Hospital B35, 4000 Liege, Belgium.
Rev Mal Respir. 2010 Oct;27(8):e47-53. doi: 10.1016/j.rmr.2009.12.003. Epub 2010 May 18.
Positron emission tomography (PET) now plays a clear role in oncology, especially in chest tumours. We discuss the value of metabolic imaging in characterising pleural pathology in the light of our own experience and review the literature.
PET is particularly useful in characterising malignant pleural pathologies and is a factor of prognosis in mesothelioma. Metabolic imaging also provides clinical information for staging lung cancer, in researching the primary tumour in metastatic pleurisy and in monitoring chronic or recurrent pleural pathologies.
PET should therefore be considered as a useful tool in the diagnosis of liquid or solid pleural pathologies.
正电子发射断层扫描(PET)目前在肿瘤学中发挥着明确的作用,尤其是在胸部肿瘤方面。我们根据自身经验探讨代谢成像在鉴别胸膜病变中的价值,并对文献进行综述。
PET在鉴别恶性胸膜病变方面特别有用,并且是间皮瘤预后的一个因素。代谢成像还为肺癌分期、研究转移性胸膜炎的原发肿瘤以及监测慢性或复发性胸膜病变提供临床信息。
因此,PET应被视为诊断液体或固体胸膜病变的有用工具。